Rodman David Malcom (CIK 0001672659)

Latest company ownership

MLYS - Mineralys Therapeutics, Inc.
Role: Chief Medical Officer
Shares held
71,155
Last filed at
Oct 15, 2025
Confidence Score
19.4
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 15, 2025 Oct 15, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 22.5 -10,369 -12.72% ✓ $446K
Sep 15, 2025 Sep 16, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 22.5 -11,367 -12.24% ✓ $409.3K
Aug 12, 2025 Aug 14, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 25.0 -11,365 -10.90% ✓ $147K
Jul 14, 2025 Jul 15, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 25.0 -11,366 -10.40% ✓ $165.9K
Jun 12, 2025 Jun 16, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 25.0 -11,366 -10.06% ✓ $165.9K
May 14, 2025 May 15, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 28.8 -11,366 -9.63% ✓ $173.8K
Apr 14, 2025 Apr 15, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 28.8 -11,366 -9.24% ✓ $165.2K
Apr 1, 2025 Apr 3, 2025 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 7.5 -55,771 -32.34% ✓ $879K
Nov 11, 2024 Nov 12, 2024 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 37.5 -5,026 -3.44% ✓ $75.4K
Nov 6, 2024 Nov 8, 2024 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 17.5 -25,482 -15.78% ✓ $383.1K
Jul 16, 2024 Jul 18, 2024 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 52.5 -525 -0.51% ✓ $7.9K
May 9, 2024 May 10, 2024 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 55.0 -100 -0.15% ✓ $1.5K
Aug 10, 2023 Aug 11, 2023 Mineralys Therapeutics, Inc. Chief Medical Officer Sell 17.5 -231,716 -100.00% ✗ $3M